Abstract:INTRODUCTION AND OBJECTIVES: According to data from SEER (http://seer.cancer.gov/) in the United States, bladder cancer (BC) has improved 5-year survival rate by only 3% in the last two decades.D-3-phosphoglycerate dehydrogenase (PHGDH) is an enzyme that converts 3-phosphoglycerate on glycolysis system and induces metabolism to serine synthesis.Cancers require serine to maintain rapid, sustained and uncontrollable proliferation.Recently it has been reported that PHGDH can be a therapeutic target in breast cancer and melanoma, on the other hand there has been no report on BC.The aim of this study is to evaluate therapeutic possibility regarding PHGDH in BC.METHODS: Clinical significance of PHGDH in BC was analyzed using The Cancer Genome Atlas (TCGA) which is a public database.In addition, the effect of PHGDH inhibitor (NCT-503) and si-RNA against PHGDH was evaluated by cell proliferation and apoptosis assay in BC cell lines (T24, BOY, KK47, UMUC-3, J82).In xenograft assay, PHGDH knockdown efficiency was investigated using sh-RNA against PHGDH.Furthermore, additive effect of the PHGDH inhibitor under Gemcitabine and Cisplatin (GC) administration was examined.RESULTS: In the PHGDH high expression group (n [ 157), the prognosis was poor (P [ 0.0032) compared with the low expression group (n [ 247), and PHGDH was found to be an independent poor prognostic factor (P [ 0.001) in multivariate analysis.The PHGDH inhibitor and PHGDH si-RNAs significantly inhibited proliferative ability through induction of apoptosis (P < 0.05) in BC cell lines.Western blot analyses showed that Ki-67 expression was markedly repressed and cleaved caspase-3 expression was increased in PHGDH knockdown BC cells compared with those in control BC cells.Additionally, cells with PHGDH overexpression promoted tumor cell viability in comparison to control cells.In xenograft assay, PHGDH knockdown by sh-RNA significantly inhibited tumor progression compared to the vehicle group (P < 0.05).Furthermore, the combination treatment between PHGDH inhibitor and GC showed synergistic tumor suppressive effect compared to each single agent group (P < 0.05) in proliferation assay.CONCLUSIONS: Our study revealed that PHGDH inhibition showed tumor suppressive effects in BC.Furthermore, the combination therapy between PHGDH inhibitor and GC showed synergistic effect in proliferation assay.Novel therapeutic implications through functional analysis of PHGDH in BC were suggested.

Inhibition of PP2A by LB100 sensitizes bladder cancer cells to chemotherapy by inducing p21 degradation

PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

Lobaplatin induces apoptosis in T24 and 5637 bladder cancer cells by regulating Bcl-2 and Bax expression and inhibiting the PI3K/Akt signaling pathway

Inhibition of Protein Phosphatase 2A Sensitizes Pancreatic Cancer to Chemotherapy by Increasing Drug Perfusion Via HIF-1α-VEGF Mediated Angiogenesis.

Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC)

Inhibition of USP1 Reverses the Chemotherapy Resistance Through Destabilization of MAX in the Relapsed/refractory B-cell Lymphoma

Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis

FL118: A potential bladder cancer therapeutic compound targeting H2A.X identified through library screening

Microtubule Dynamics Deregulation Induces Apoptosis in Human Urothelial Bladder Cancer Cells via a p53-Independent Pathway

Targeting Dna Damage and Repair Machinery via Delivering WEE1 Inhibitor and Platinum (IV) Prodrugs to Stimulate Sting Pathway for Maximizing Chemo‐immunotherapy in Bladder Cancer

Gene splicing dominates review of weapons pact.

UPP1 enhances bladder cancer progression and gemcitabine resistance through AKT

MP51-06 SMYD3 INHIBITION INDUCES PROTECTIVE AUTOPHAGY IN BLADDER CANCER VIA MTOR PATHWAY

PPP3CB Inhibits Cell Proliferation and the Warburg Effect in Bladder Cancer by Blocking PDHK1

Acute water intoxication as a complication of urine drug testing in the workplace.

CIP2A depletion potentiates the chemosensitivity of cisplatin by inducing increased apoptosis in bladder cancer cells.

Supplementary Tables 1 and 2 and Supplementary Figures 1 Through 7 from Inhibition of Protein Phosphatase 2A Enhances Cytotoxicity and Accessibility of Chemotherapeutic Drugs to Hepatocellular Carcinomas

Data from Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair

Extension of range of functions

Inhibition of Bruton's Tyrosine Kinase Suppresses Cancer Stemness and Promotes Carboplatin-induced Cytotoxicity Against Bladder Cancer Cells

Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy